Functional interactions between cannabinoids, omega‐3 fatty acids, and peroxisome proliferator‐activated receptors: Implications for mental health pharmacotherapies-Reference-Cited by-同舟云学术

Functional interactions between cannabinoids, omega‐3 fatty acids, and peroxisome proliferator‐activated receptors: Implications for mental health pharmacotherapies

Published:2020-12-20 Issue: Volume: Page:
ISSN:0953-816X
Container-title:European Journal of Neuroscience
language:en
Short-container-title:Eur J Neurosci

Author:

Jung Tony¹²,Hudson Roger¹²,Rushlow Walter¹²³,Laviolette Steven R.¹²³^ORCID

Affiliation:

1. Addiction Research Group Schulich School of Medicine & Dentistry University of Western Ontario London ON Canada

2. Department of Anatomy & Cell Biology Schulich School of Medicine & Dentistry University of Western Ontario London ON Canada

3. Department of Psychiatry Schulich School of Medicine & Dentistry University of Western Ontario London ON Canada

Funder

Mitacs

Natural Sciences and Engineering Research Council of Canada

Canadian Institutes of Health Research

Health Research

Science and Engineering Research Council

Publisher

Wiley

Subject

General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejn.15023

Reference118 articles.

1. Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspective

2. Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders

3. Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study

4. Schizophrenia in users and nonusers of cannabis.

5. CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid Therapy in Athletics: A Review of Current Cannabis Research to Evaluate Potential Real-World Cannabinoid Applications in Sport;Sports Medicine;2024-08-21

2. New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-07

3. Cannabidiol is a behavioral modulator in BTBR mouse model of idiopathic autism;Frontiers in Neuroscience;2024-05-09

4. Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation;Frontiers in Cardiovascular Medicine;2024-04-18

5. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders;Basic & Clinical Pharmacology & Toxicology;2024-03-13